Literature DB >> 18450756

Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment.

Ghada Abboud-Jarrous1, Ruth Atzmon, Tamar Peretz, Carmela Palermo, Bedrick B Gadea, Johanna A Joyce, Israel Vlodavsky.   

Abstract

Heparanase is an endo-beta-d-glucuronidase that degrades heparan sulfate in the extracellular matrix and on the cell surface. Human proheparanase is produced as a latent protein of 543 amino acids whose activation involves excision of an internal linker segment (Ser(110)-Gln(157)), yielding the active heterodimer composed of 8- and 50-kDa subunits. Applying cathepsin L knock-out tissues and cultured fibroblasts, as well as cathepsin L gene silencing and overexpression strategies, we demonstrate, for the first time, that removal of the linker peptide and conversion of proheparanase into its active 8 + 50-kDa form is brought about predominantly by cathepsin L. Excision of a 10-amino acid peptide located at the C terminus of the linker segment between two functional cathepsin L cleavage sites (Y156Q and Y146Q) was critical for activation of proheparanase. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry demonstrates that the entire linker segment is susceptible to multiple endocleavages by cathepsin L, generating small peptides. Mass spectrometry demonstrated further that an active 8-kDa subunit can be generated by several alternative adjacent endocleavages, yielding the precise 8-kDa subunit and/or slightly elongated forms. Altogether, the mode of action presented here demonstrates that processing and activation of proheparanase can be brought about solely by cathepsin L. The critical involvement of cathepsin L in proheparanase processing and activation offers new strategies for inhibiting the prometastatic, proangiogenic, and proinflammatory activities of heparanase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450756      PMCID: PMC2440611          DOI: 10.1074/jbc.M801327200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Heparanase: a key enzyme involved in cell invasion.

Authors:  C R Parish; C Freeman; M D Hulett
Journal:  Biochim Biophys Acta       Date:  2001-03-21

2.  Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.

Authors:  W Roth; J Deussing; V A Botchkarev; M Pauly-Evers; P Saftig; A Hafner; P Schmidt; W Schmahl; J Scherer; I Anton-Lamprecht; K Von Figura; R Paus; C Peters
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

3.  Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.

Authors:  Irena Zajc; Natasa Sever; Ales Bervar; Tamara T Lah
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

4.  Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids.

Authors:  F Lecaille; E Authié; T Moreau; C Serveau; F Gauthier; G Lalmanach
Journal:  Eur J Biochem       Date:  2001-05

5.  Heparanase expression in primary and metastatic pancreatic cancer.

Authors:  A Koliopanos; H Friess; J Kleeff; X Shi; Q Liao; I Pecker; I Vlodavsky; A Zimmermann; M W Büchler
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

6.  Heparanase protein and gene expression in bladder cancer.

Authors:  K Gohji; M Okamoto; S Kitazawa; M Toyoshima; J Dong; Y Katsuoka; M Nakajima
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

7.  An alternate targeting pathway for procathepsin L in mouse fibroblasts.

Authors:  Kyujeong Ahn; Susan Yeyeodu; John Collette; Victoria Madden; Joshua Arthur; Lian Li; Ann H Erickson
Journal:  Traffic       Date:  2002-02       Impact factor: 6.215

8.  Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.

Authors:  Edward McKenzie; Kathryn Young; Margaret Hircock; James Bennett; Maina Bhaman; Robert Felix; Paul Turner; Alasdair Stamps; David McMillan; Giles Saville; Stanley Ng; Sean Mason; Daniel Snell; Darren Schofield; Haiping Gong; Reid Townsend; John Gallagher; Martin Page; Raj Parekh; Colin Stubberfield
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

Review 9.  Cysteine cathepsin proteases as pharmacological targets in cancer.

Authors:  Carmela Palermo; Johanna A Joyce
Journal:  Trends Pharmacol Sci       Date:  2007-11-26       Impact factor: 14.819

10.  Involvement of disulfide bond formation in the activation of heparanase.

Authors:  Siro Simizu; Takehiro Suzuki; Makoto Muroi; Ngit Shin Lai; Satoshi Takagi; Naoshi Dohmae; Hiroyuki Osada
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

View more
  72 in total

1.  Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.

Authors:  Immanuel Lerner; Esther Hermano; Eyal Zcharia; Dina Rodkin; Raanan Bulvik; Victoria Doviner; Ariel M Rubinstein; Rivka Ishai-Michaeli; Ruth Atzmon; Yoav Sherman; Amichay Meirovitz; Tamar Peretz; Israel Vlodavsky; Michael Elkin
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

2.  Significance of heparanase in cancer and inflammation.

Authors:  Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin
Journal:  Cancer Microenviron       Date:  2011-08-03

3.  Heparanase and cancer progression: New directions, new promises.

Authors:  Gil Arvatz; Marina Weissmann; Neta Ilan; Israel Vlodavsky
Journal:  Hum Vaccin Immunother       Date:  2016-04-07       Impact factor: 3.452

4.  Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells.

Authors:  James Hopkins; Tejabhiram Yadavalli; Alex M Agelidis; Deepak Shukla
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

5.  A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Gil Arvatz; Svetlana Gingis-Velitski; Flonia Levy-Adam; Ofer Nativ; Ronen Shemesh; Michal Ayalon-Sofer; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

Review 6.  Versatile role of heparanase in inflammation.

Authors:  Rachel Goldberg; Amichay Meirovitz; Nir Hirshoren; Raanan Bulvik; Adi Binder; Ariel M Rubinstein; Michael Elkin
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

Review 7.  Involvement of heparanase in atherosclerosis and other vessel wall pathologies.

Authors:  Israel Vlodavsky; Miry Blich; Jin-Ping Li; Ralph D Sanderson; Neta Ilan
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

8.  Heparin enhances serpin inhibition of the cysteine protease cathepsin L.

Authors:  Wayne J Higgins; Denise M Fox; Piotr S Kowalski; Jens E Nielsen; D Margaret Worrall
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

Review 9.  Diverse cell signaling events modulated by perlecan.

Authors:  John M Whitelock; James Melrose; Renato V Iozzo
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

10.  Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.

Authors:  Menachem Bitan; Lola Weiss; Michael Zeira; Eyal Zcharia; Shimon Slavin; Arnon Nagler; Israel Vlodavsky
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.